uniQure (Nasdaq: QURE) has been a public company since 2014.

We thank our investors for their support as we advance our gene therapy pipeline toward commercialization.
Contact us at any time.

uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We have developed a modular platform to rapidly bring new disease modifying therapies to patients with severe disorders.

We are leveraging our modular and validated technology platform to rapidly advance a focused pipeline of gene therapies.

Stock Quote

Recent NewsO

Webcast Archive: 

June 9, 2017
Jefferies Healthcare Conference
Friday, June 9, 2017 
8:00 a.m. EDT/ 2:00 p.m. CET
Click here to view webcast

May 23, 2017

UBS Global Healthcare Conference
Tuesday, May 23, 2017
3:00 p.m. EDT/ 9:00 p.m. CET
Click here to view webcast
May 12, 2017
Investor and Analyst Breakfast & Webcast 
Friday, May 12, 2017
07:00 a.m. EDT/ 13:00 CET

Click here to view webcast

 Upcoming Events:

September 6-7, 2017
CITI 12th Annual Biotech Conference, Boston, MA 

October 4-5, 2017
ARM Cell & Gene Meeting on the Mesa, La Jolla, CA